Cargando…
Cellular Therapies in Chronic Granulomatous Disease
Allogeneic hematopoietic stem cell transplantation (HSCT) has become the main curative treatment in patients with chronic granulomatous disease (CGD). CGD is caused by inherited defects of the phagolysomal NADPH-oxidase, leading to a lifelong propensity for invasive infections and granulomatous infl...
Autores principales: | Güngör, Tayfun, Chiesa, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333593/ https://www.ncbi.nlm.nih.gov/pubmed/32676488 http://dx.doi.org/10.3389/fped.2020.00327 |
Ejemplares similares
-
Papulopustular Dermatitis in X-Linked Chronic Granulomatous Disease
por: Rajani, Puja Sood, et al.
Publicado: (2019) -
Unexpected cystoscopic images in a patient with Chronic Granulomatous Disease
por: Kowalczyk, Kinga, et al.
Publicado: (2023) -
A Novel Mutation in Chronic Granulomatous Disease: Treating the Family, Not Just the Patient
por: Lutzkanin, Kristen, et al.
Publicado: (2019) -
Candida Glabrata Lymphadenitis Following Infliximab Therapy for Inflammatory Bowel Disease in a Patient With Chronic Granulomatous Disease: Case Report and Literature Review
por: Lehman, Heather Kristin, et al.
Publicado: (2021) -
Case report: Chronic granulomatous disease presenting with early-onset inflammatory bowel disease and normal oxidative burst testing
por: Mondal, Sanjib, et al.
Publicado: (2023)